{"corpus_id":26614083,"paper_sha":"292c972cee2b17f8acc66dd286cd6b424007028c","doi":"10.1021/JS9601896","arxiv_id":null,"pmid":9002452,"pmcid":null,"mag_id":2951673900,"dblp_id":null,"acl_id":null,"title":"Characteristics and significance of the amorphous state in pharmaceutical systems.","year":1997,"publication_date":"1997-03-25","venue":"Journal of Pharmacy and Science","journal":{"name":"Journal of pharmaceutical sciences","pages":"\n          1-12\n        ","volume":"86 1"},"journal_issn":null,"journal_title":null,"publication_types":["Review","JournalArticle"],"pubmed_pub_types":["Journal Article","Review"],"s2_fields_of_study":["Medicine","Materials Science","Chemistry"],"reference_count":106,"citation_count":1872,"influential_citation_count":43,"is_open_access":false,"arxiv_categories":null,"arxiv_license":null,"arxiv_journal_ref":null,"mesh_headings":[{"d":"Chemistry, Pharmaceutical","mj":true,"ui":"D002626"},{"d":"Crystallization","mj":false,"ui":"D003460"},{"d":"X-Ray Diffraction","mj":false,"ui":"D014961"}],"chemicals":null,"comments_corrections":null,"source_flags":5,"s2_open_access_pdf_url":null,"s2_open_access_landing_url":null,"s2_open_access_license":null,"s2_open_access_status":null,"pmc_open_access_pdf_url":null,"pmc_open_access_landing_url":null,"pmc_open_access_license":null,"pmc_open_access_status":null,"unpaywall_open_access_pdf_url":null,"unpaywall_open_access_landing_url":null,"unpaywall_open_access_license":null,"unpaywall_open_access_status":null,"abstract":"The amorphous state is critical in determining the solid-state physical and chemical properties of many pharmaceutical dosage forms. This review describes the characteristics of the amorphous state and some of the most common methods that can be used to measure them. Examples of pharmaceutical situations where the presence of the amorphous state plays an important role are presented. The application of our current knowledge to pharmaceutical formulation problems is illustrated, and some strategies for working with amorphous character in pharmaceutical systems are provided.","claims":[{"public_id":"cl_226a613852fede74ee8beb1f2d73099d","status":"active","text":"Common methods for measuring characteristics of the amorphous state are described.","confidence":0.9,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_226a613852fede74ee8beb1f2d73099d"},{"public_id":"cl_dcd8097e24919efd1a750413e248da6a","status":"active","text":"Current knowledge about amorphous character is applied to pharmaceutical formulation problems.","confidence":0.86,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_dcd8097e24919efd1a750413e248da6a"},{"public_id":"cl_6b59e7f168c4bf01522da3963122df4e","status":"active","text":"Pharmaceutical examples are presented in which the presence of the amorphous state is important.","confidence":0.9,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_6b59e7f168c4bf01522da3963122df4e"},{"public_id":"cl_dceff82f9d241a0541b006acfdedc807","status":"active","text":"Strategies for working with amorphous character in pharmaceutical systems are provided.","confidence":0.87,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_dceff82f9d241a0541b006acfdedc807"},{"public_id":"cl_938f72fc97dc6ecfa4b643e29cfa4a21","status":"active","text":"The amorphous state plays a critical role in determining the solid-state physical and chemical properties of many pharmaceutical dosage forms.","confidence":0.95,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_938f72fc97dc6ecfa4b643e29cfa4a21"}],"concepts":[{"public_id":"co_0298805c4eecef67322804cbd3828ee5","status":"active","name":"solid-state physical and chemical properties","description":"Physical and chemical characteristics of a material in its solid form.","types":["properties"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_0298805c4eecef67322804cbd3828ee5"},{"public_id":"co_093e15f92dbee0e60fe249241ae77184","status":"active","name":"measurement methods","description":"Methods used to assess or quantify properties of a material.","types":["method"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_093e15f92dbee0e60fe249241ae77184"},{"public_id":"co_339e326f812bf1f07d8aeacddebf9450","status":"active","name":"amorphous state","description":"A non-crystalline solid-state form of a pharmaceutical material.","types":["material state"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_339e326f812bf1f07d8aeacddebf9450"},{"public_id":"co_3ac64ba873090893215af7c00d9ea102","status":"active","name":"pharmaceutical systems","description":"Materials and compositions used in pharmaceutical applications.","types":["system"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_3ac64ba873090893215af7c00d9ea102"},{"public_id":"co_4c14f7cf72e025e45cf12584ed801914","status":"active","name":"pharmaceutical formulation problems","description":"Challenges involved in designing and preparing pharmaceutical formulations.","types":["problem"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_4c14f7cf72e025e45cf12584ed801914"},{"public_id":"co_5322cfc36c7f18951d59e68753ee4f7d","status":"active","name":"amorphous character","description":"The extent or presence of amorphous nature in a pharmaceutical system.","types":["property"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_5322cfc36c7f18951d59e68753ee4f7d"},{"public_id":"co_7295902f2084b3fb438a804fe537f345","status":"active","name":"characteristics of the amorphous state","description":"The defining properties associated with amorphous pharmaceutical materials.","types":["properties"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_7295902f2084b3fb438a804fe537f345"},{"public_id":"co_98141e94ca7c39b9cdc410a991d541a6","status":"active","name":"pharmaceutical dosage forms","description":"The physical forms in which pharmaceutical products are administered.","types":["product form"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_98141e94ca7c39b9cdc410a991d541a6"},{"public_id":"co_d82ca7dc9393187268243419a873ef63","status":"active","name":"strategies","description":"Approaches used to manage or exploit amorphous character in pharmaceutical contexts.","types":["approach"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_d82ca7dc9393187268243419a873ef63"},{"public_id":"co_fe88bca27861b50554c55b3c887e68a4","status":"active","name":"pharmaceutical situations","description":"Pharmaceutical contexts or cases where amorphous material is relevant.","types":["context"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_fe88bca27861b50554c55b3c887e68a4"}],"external_ids":{"DOI":"10.1021/JS9601896","ArXiv":null,"PubMed":9002452,"PubMedCentral":null,"MAG":2951673900,"DBLP":null,"ACL":null},"open_access":{"is_open_access":false,"pdf_url":null,"landing_url":"https://sah.borca.ai/papers/26614083","source":null,"pdf_url_source":null,"license":null,"reason":"pdf_url_not_indexed"},"reference_availability":{"status":"available","references_indexed":true,"full_text_available":false,"full_text_source":null,"count_basis":"semantic_scholar_metadata","extraction_status":"not_applicable","reason":null},"source":{"provider":"episteme2","base_corpus":"semantic_scholar_dump","freshness_mode":"unknown","basis":["semantic_scholar_metadata","postgres_metadata"],"limits":["paper metadata is based on indexed upstream scholarly datasets","claims and concepts are available only for extracted papers","absence of claims or concepts means no extracted graph data is available in this response"],"status":"available","degraded":false,"degraded_reasons":[],"diagnostics":{"status":"available","degraded":false,"degraded_reasons":[],"metadata_status":"available","graph_status":"available","abstract_status":"available"},"source_flags":5},"paper_id":631486,"paper_uid":"b1ef422f-558d-4197-919a-2f1d2ecfa5ec","canonical_identity":{"paper_id":631486,"paper_uid":"b1ef422f-558d-4197-919a-2f1d2ecfa5ec","identity_status":"available","lookup_basis":"semantic_scholar_external_id","compatibility_path":"corpus_id"},"url":"https://sah.borca.ai/papers/26614083"}